Hui-zi Z. Chen

Hui-zi Z. Chen

Oncology
8800 W. Doyne Ave.
Milwaukee, WI 53226

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

Universal Germline Genetic Testing in a Precision Oncology and Rare Cancer Clinic: Implementation and Outcomes.

Universal Germline Genetic Testing in a Precision Oncology and Rare Cancer Clinic: Implementation and Outcomes.

Journal: JCO oncology advances
Published: July 09, 2026

Navigating Complexity in the Precision Oncology Clinic: Pharmacists' Central Role in Drug Selection, Acquisition, and Dosing in a Real-World Clinic.

Navigating Complexity in the Precision Oncology Clinic: Pharmacists' Central Role in Drug Selection, Acquisition, and Dosing in a Real-World Clinic.

Journal: Journal of immunotherapy and precision oncology
Published: April 22, 2026

Genome-wide Mapping of Histone Modifications and Transcription Factor Binding Sites in Neuroendocrine Small Cell Lung Cancer Cell Lines Using CUT&RUN.

Genome-wide Mapping of Histone Modifications and Transcription Factor Binding Sites in Neuroendocrine Small Cell Lung Cancer Cell Lines Using CUT&RUN.

Journal: Journal of visualized experiments : JoVE
Published: April 20, 2026

EZH2 Inhibition Reshapes 3D Chromatin Architecture to Induce Immunogenic Phenotype in Small Cell Lung Cancer.

EZH2 Inhibition Reshapes 3D Chromatin Architecture to Induce Immunogenic Phenotype in Small Cell Lung Cancer.

Journal: bioRxiv : the preprint server for biology
Published: February 09, 2026

Pre-treatment polyfunctionality percentage (PFA) of CD8+ T cells is associated with development of immune-related adverse events (irAEs) in patients receiving immune checkpoint inhibitors (ICIs).

Pre-treatment polyfunctionality percentage (PFA) of CD8+ T cells is associated with development of immune-related adverse events (irAEs) in patients receiving immune checkpoint inhibitors (ICIs).

Journal: Neoplasia (New York, N.Y.)
Published: December 04, 2025

CHIMERA-DDR: A Machine Learning Framework for Classifying Heterogeneous Mismatch-Repair and Homologous-Recombination Deficiency Patterns in Prostate Cancer.

CHIMERA-DDR: A Machine Learning Framework for Classifying Heterogeneous Mismatch-Repair and Homologous-Recombination Deficiency Patterns in Prostate Cancer.

Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025

Cancer treatment paradigms in the precision medicine era.

Cancer treatment paradigms in the precision medicine era.

Journal: Nature medicine
Published: May 20, 2025

Successful Targeting of Somatic VHL Alterations With Belzutifan in Two Cases.

Successful Targeting of Somatic VHL Alterations With Belzutifan in Two Cases.

Journal: Journal of immunotherapy and precision oncology
Published: March 26, 2024

PD-1 transcriptomic landscape across cancers and implications for immune checkpoint blockade outcome.

PD-1 transcriptomic landscape across cancers and implications for immune checkpoint blockade outcome.

Journal: NPJ genomic medicine
Published: December 19, 2023

Manzamine A reduces androgen receptor transcription and synthesis by blocking E2F8-DNA interactions and effectively inhibits prostate tumor growth in mice.

Manzamine A reduces androgen receptor transcription and synthesis by blocking E2F8-DNA interactions and effectively inhibits prostate tumor growth in mice.

Journal: Molecular oncology
Published: November 03, 2023

ALK fusions in the pan-cancer setting: another tumor-agnostic target?

ALK fusions in the pan-cancer setting: another tumor-agnostic target?

Journal: NPJ precision oncology
Published: April 02, 2023

Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake.

Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake.

Journal: Familial cancer
Published: February 05, 2022
Showing 1-12 of 27

Last Updated: 09/26/2026